NASDAQ - TELK +11% gap in the pre-market

"(RTTNews) - Telik Says Triplet Combination Was Generally Well-tolerated At All TELCYTA Doses Evaluated, With Toxicities Similar To Those Expected With Each Drug Alone "

http://daytradingstocksoptions.blogspot.com/